News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

An Investor's Guide to the New PDUFA


7/17/2007 11:18:48 PM

It's important for investors in drug companies to keep up with the latest clinical trial news, but policy changes in Washington can affect companies' bottom lines just as much. Last week the House passed a bill reauthorizing the Prescription Drug User Fee Act (PDUFA); let's take a look at how it will affect drugmakers.

Read at Motley Fool

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES